# Zhejiang Cheng Yi Pharmaceutical Co., Ltd., Wenzhou, China – FDA Inspections

Source: https://www.keypedia.com/companies/zhejiang-cheng-yi-pharmaceutical-co-ltd/dabc68a0-9969-418a-9cd6-54e9987ed8df

> Inspection records and compliance data for Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in Wenzhou. 5 FDA inspections on record, 1 Form 483, last inspected March 07, 2025.

---

## Details

- Name: Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
- FEI Number: 3004090742
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: 118 Hua Gong Road, Dongtou District
- City: Wenzhou
- Country Name: China
- Address: 118 Hua Gong Road, Dongtou District, Wenzhou, China
- Country: China

## Related Documents

- [FDA Inspection 1265837 - Zhejiang Cheng Yi Pharmaceutical Co., Ltd. - 2025-03-07](https://www.keypedia.com/records/fda_inspections/zhejiang-cheng-yi-pharmaceutical-co-ltd/7a6c43ae-236c-4cbb-b540-57813800fccc) — source: FDA, date: March 7, 2025
- FDA Inspection 1265837 - Zhejiang Cheng Yi Pharmaceutical Co., Ltd. - 2025-03-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 7, 2025
- [483 - Zhejiang Cheng Yi Pharmaceutical Co., Ltd. - 2019-11-22](https://www.keypedia.com/records/483/zhejiang-cheng-yi-pharmaceutical-co-ltd/302353b0-20f8-49d1-931a-4554d52b9927) — source: FDA, date: November 22, 2019
- [FDA Inspection 1111465 - Zhejiang Cheng Yi Pharmaceutical Co., Ltd. - 2019-11-22](https://www.keypedia.com/records/fda_inspections/zhejiang-cheng-yi-pharmaceutical-co-ltd/3f7e8a81-98dc-42f2-beea-10147a0b6609) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2019
- [FDA Inspection 985172 - Zhejiang Cheng Yi Pharmaceutical Co., Ltd. - 2016-07-15](https://www.keypedia.com/records/fda_inspections/zhejiang-cheng-yi-pharmaceutical-co-ltd/3fc13e2e-a088-41d6-8d9d-1aa9ff21a885) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2016
- FDA Inspection 879798 - Zhejiang Cheng Yi Pharmaceutical Co., Ltd. - 2014-03-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 14, 2014
- FDA Inspection 701018 - Zhejiang Cheng Yi Pharmaceutical Co., Ltd. - 2010-09-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 9, 2010

## Related Companies

- [Jiangxi Synergy Pharmaceutical, Co., Ltd.](https://www.keypedia.com/companies/jiangxi-synergy-pharmaceutical-co-ltd/9602f29a-9a10-4201-966c-b89b6a2d3ae5)
- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [Aarti Pharmalabs Limited](https://www.keypedia.com/companies/aarti-pharmalabs-limited/94a0adf3-5840-4cc1-9582-8eafd52d498e)
- [Arch Pharmalabs Ltd.](https://www.keypedia.com/companies/arch-pharmalabs-ltd/2766781c-7a1a-4718-bb0e-04fa9616a574)
- [Natco Pharma Ltd. - Chemical Division](https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1)
- [Zach System S.A.](https://www.keypedia.com/companies/zach-system-sa/c663917a-2b9d-4375-bc79-2cdd0e280002)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Albemarle US, Inc.](https://www.keypedia.com/companies/albemarle-us-inc/336600a7-808b-4d7d-bfc0-7a9e728aa0aa)
- [Huber Soda, LLC](https://www.keypedia.com/companies/huber-soda-llc/89d2a595-ba2c-46a2-987c-65bb21b1b75b)
- [Somerville Acquisitions, Inc.](https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb)

## Related Officers

- [Santos E. Camara](https://www.keypedia.com/people/santos-e-camara/18cea942-f6f9-4dec-9ce9-1c01c39009ce)